BMS 300 mg 3622 (Reyataz 300 mg)

Generic Name: atazanavir

Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Reyataz 300 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 300 mg 3622

Reyataz

Generic Name:

atazanavir

Imprint:

BMS 300 mg 3622

Strength:

300 mg

Color:

Red / Blue

Size:

23.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Protease inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Bristol-Myers Squibb

Inactive Ingredients:

crospovidone
lactose monohydrate
magnesium stearate
gelatin
FD&C Blue No. 2
titanium dioxide
ferric oxide red
ferric oxide yellow
isopropyl alcohol
ammonia
propylene glycol
butyl alcohol
alcohol
ferrosoferric oxide
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
54569-5864	A-S Medication Solutions, LLC (repackager)
54868-5838	Physicians Total Care Inc. (repackager)
35356-0114	Lake Erie Medical and Surgical Supply (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.